UB Paderborn / Katalog / Suche / in CDI

Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling

Journal of the American College of Cardiology, 2018-12, Vol.72 (25), p.3370-3372

2018

Volltextzugriff (PDF)

Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults

Journal of the American College of Cardiology, 2020-03, Vol.75 (9), p.1003-1013

2020

Volltextzugriff (PDF)

Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis

PLoS medicine, 2019-04, Vol.16 (4), p.e1002797

2019

Volltextzugriff (PDF)

Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics

Arteriosclerosis, thrombosis, and vascular biology, 2015-08, Vol.35 (8), p.1880

2015

Volltextzugriff (PDF)

Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021

Trends in cardiovascular medicine, 2021-04, Vol.31 (3), p.135-140

2021

Volltextzugriff (PDF)

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy

JACC CardioOncology, 2019-09, Vol.1 (1), p.54-65

2019

Volltextzugriff (PDF)

Effects of Niacin , Statin , and Fenofibrate on Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels in Patients With Dyslipidemia

The American journal of cardiology, 2015-01, Vol.115 (2), p.178-182

2015

Volltextzugriff (PDF)

Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD

Journal of the American College of Cardiology, 2019-07, Vol.74 (4), p.578-586

2019

Volltextzugriff (PDF)

Impact of Diabetes on Outcomes in Patients Hospitalized With Acute Myocardial Infarction: Insights From the Atherosclerosis Risk in Communities Study Community Surveillance

Journal of the American Heart Association, 2023-05, Vol.12 (10), p.e028923-e028923

2023

Volltextzugriff (PDF)

Impact of Type 2 Myocardial Infarction (MI) on Hospital‐Level MI Outcomes: Implications for Quality and Public Reporting

Journal of the American Heart Association, 2018-04, Vol.7 (7), p.n/a

2018

Volltextzugriff (PDF)

Epidemiological profile and clinical outcomes of very young (<35 years) and young (35–50 years) patients with STEMI: Insights from the NORIN STEMI registry

Indian heart journal, 2024-03, Vol.76 (2), p.128-132

2024

Volltextzugriff (PDF)

Safety and Tolerability of Transitioning from Cangrelor to Ticagrelor in Patients Who Underwent Percutaneous Coronary Intervention

The American journal of cardiology, 2017-08, Vol.120 (3), p.359-361

2017

Volltextzugriff (PDF)

Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000-2014

Journal of the American Heart Association, 2018-10, Vol.7 (19), p.e010203-e010203

2018

Volltextzugriff (PDF)

Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance

Journal of the American Heart Association, 2023-07, Vol.12 (13), p.e027851-e027851

2023

Volltextzugriff (PDF)

Trends in Veno-Arterial Extracorporeal Life Support With and Without an Impella or Intra-Aortic Balloon Pump for Cardiogenic Shock

Journal of the American Heart Association, 2022-12, Vol.11 (23), p.e025216-e025216

2022

Volltextzugriff (PDF)

Trends in Inpatient Complications After Transcatheter and Surgical Aortic Valve Replacement in the Transcatheter Aortic Valve Replacement Era

Circulation. Cardiovascular interventions, 2018-11, Vol.11 (11), p.e007517-e007517

2018

Volltextzugriff (PDF)

Trends, Management, and Outcomes of Acute Myocardial Infarction Hospitalizations With In-Hospital-Onset Versus Out-of-Hospital Onset: The ARIC Study

Journal of the American Heart Association, 2021-01, Vol.10 (2), p.e018414-e018414

2021

Volltextzugriff (PDF)

Bradyarrhythmias in patients with COVID-19: A case series

Indian pacing and electrophysiology journal, 2020-09, Vol.20 (5), p.211-212

2020

Volltextzugriff (PDF)

Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time?

Annals of internal medicine, 2020-01, Vol.172 (2), p.149

2020

Volltextzugriff (PDF)

COVID 19-related burnout among healthcare workers in India and ECG based predictive machine learning model: Insights from the BRUCEE- Li study

Indian heart journal, 2021-11, Vol.73 (6), p.674-681

2021

Volltextzugriff (PDF)

On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study)

The American journal of cardiology, 2015-09, Vol.116 (5), p.694-698

2015

Volltextzugriff (PDF)

Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India

ESC Heart Failure, 2022-12, Vol.9 (6), p.3836-3845

2022

Volltextzugriff (PDF)

Beta-Blocker Therapy After Myocardial Infarction: Is There an Expiry Date?

Canadian journal of cardiology, 2020-10, Vol.36 (10), p.1577-1579

2020

Volltextzugriff (PDF)

Grim messenger: Virchow’s Node Presenting with Virchow’s Triad

The American journal of medicine, 2016-09, Vol.129 (9), p.948-951

2016

Volltextzugriff (PDF)

Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk

International journal of cardiology. Heart & vasculature, 2022-12, Vol.43, p.101136-101136, Article 101136

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling

Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults

Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis

Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics

Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy

Effects of Niacin , Statin , and Fenofibrate on Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels in Patients With Dyslipidemia

Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD

Impact of Diabetes on Outcomes in Patients Hospitalized With Acute Myocardial Infarction: Insights From the Atherosclerosis Risk in Communities Study Community Surveillance

Impact of Type 2 Myocardial Infarction (MI) on Hospital‐Level MI Outcomes: Implications for Quality and Public Reporting

Epidemiological profile and clinical outcomes of very young (<35 years) and young (35–50 years) patients with STEMI: Insights from the NORIN STEMI registry

Safety and Tolerability of Transitioning from Cangrelor to Ticagrelor in Patients Who Underwent Percutaneous Coronary Intervention

Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000-2014

Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance

Trends in Veno-Arterial Extracorporeal Life Support With and Without an Impella or Intra-Aortic Balloon Pump for Cardiogenic Shock

Trends in Inpatient Complications After Transcatheter and Surgical Aortic Valve Replacement in the Transcatheter Aortic Valve Replacement Era

Trends, Management, and Outcomes of Acute Myocardial Infarction Hospitalizations With In-Hospital-Onset Versus Out-of-Hospital Onset: The ARIC Study

Bradyarrhythmias in patients with COVID-19: A case series

Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time?

COVID 19-related burnout among healthcare workers in India and ECG based predictive machine learning model: Insights from the BRUCEE- Li study

On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study)

Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India

Beta-Blocker Therapy After Myocardial Infarction: Is There an Expiry Date?

Grim messenger: Virchow’s Node Presenting with Virchow’s Triad

Reclassification of coronary artery disease risk using genetic risk score among subjects with borderline or intermediate clinical risk

Suchergebnisse filtern